Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Reis

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
The American Journal of Medicine|January 9, 2003
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, Marian B Olson, B Delia Johnson, et al.
Behavior Modification|February 18, 2003
Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The WISE StudyThomas Rutledge, Steven E Reis, Marian Olson, et al.
American Heart Journal|November 18, 2005
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, Leslee J Shaw, et al.
Clinical Cardiology|December 21, 2002
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: results from the NHLBI WISE StudyRichard Holubkov, Carl J Pepine, Cheryl Rickens, et al.
American Heart Journal|June 17, 2004
Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyAnthony P Morise, Marian B Olson, C Noel Bairey Merz, et al.
Journal of Women'S Health (2002)|May 25, 2007
Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) StudyCarl J Pepine, Gregory O von Mering, Richard A Kerensky, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 1, 2017
Association of remote ischemic peri-conditioning with reduced incidence of clinical heart failure after primary percutaneous coronary interventionAdetola Ladejobi, Max Wayne, Christian Martin-Gill, et al.
Ebiomedicine|January 10, 2025
Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease eventsAnum Saeed, Chris McKennan, Jiaxuan Duan, et al.
Psychosomatic Medicine|November 27, 2004
Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation studyThomas Rutledge, Steven E Reis, Marian Olson, et al.
Menopause (New York, N.Y.)|May 3, 2011
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChrisandra L Shufelt, B Delia Johnson, Sarah L Berga, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
The American Journal of Medicine|January 9, 2003
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, Marian B Olson, B Delia Johnson, et al.
Behavior Modification|February 18, 2003
Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The WISE StudyThomas Rutledge, Steven E Reis, Marian Olson, et al.
American Heart Journal|November 18, 2005
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, Leslee J Shaw, et al.
Clinical Cardiology|December 21, 2002
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: results from the NHLBI WISE StudyRichard Holubkov, Carl J Pepine, Cheryl Rickens, et al.
American Heart Journal|June 17, 2004
Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyAnthony P Morise, Marian B Olson, C Noel Bairey Merz, et al.
Journal of Women'S Health (2002)|May 25, 2007
Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) StudyCarl J Pepine, Gregory O von Mering, Richard A Kerensky, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 1, 2017
Association of remote ischemic peri-conditioning with reduced incidence of clinical heart failure after primary percutaneous coronary interventionAdetola Ladejobi, Max Wayne, Christian Martin-Gill, et al.
Ebiomedicine|January 10, 2025
Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease eventsAnum Saeed, Chris McKennan, Jiaxuan Duan, et al.
Psychosomatic Medicine|November 27, 2004
Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation studyThomas Rutledge, Steven E Reis, Marian Olson, et al.
Menopause (New York, N.Y.)|May 3, 2011
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChrisandra L Shufelt, B Delia Johnson, Sarah L Berga, et al.
Pageof 19